Schonfeld Strategic Advisors LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 215 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$746,645
+64.1%
68,752
+227.5%
0.01%
+66.7%
Q4 2023$454,895
-82.9%
20,992
-83.8%
0.00%
-85.7%
Q3 2023$2,663,443
+172.0%
129,419
+521.5%
0.02%
+162.5%
Q2 2023$979,097
+72.6%
20,823
+40.0%
0.01%
+60.0%
Q4 2022$567,218
+57.6%
14,872
+61.6%
0.01%
+66.7%
Q3 2022$360,000
-34.8%
9,204
-44.8%
0.00%
-40.0%
Q1 2022$552,000
-51.9%
16,680
+8.8%
0.01%
-64.3%
Q1 2021$1,147,000
-31.2%
15,333
-61.8%
0.01%
-36.4%
Q2 2020$1,668,000
+658.2%
40,100
+422.9%
0.02%
+57.1%
Q1 2020$220,000
-14.4%
7,669
+115.5%
0.01%
+133.3%
Q4 2019$257,000
-88.8%
3,558
-78.3%
0.01%
-91.2%
Q3 2019$2,300,000
+83.0%
16,400
+84.3%
0.07%
+21.4%
Q3 2018$1,257,000
+83.8%
8,900
+3.7%
0.06%
-21.1%
Q2 2017$684,000
-51.4%
8,586
-71.9%
0.07%
-70.3%
Q3 2016$1,408,000
+367.8%
30,567
+205.7%
0.24%
+256.7%
Q2 2016$301,000
-17.8%
10,000
-12.4%
0.07%
-55.0%
Q1 2016$366,00011,4190.15%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Rock Ventures, LLC 9,773,073$490,901,00052.36%
Ghost Tree Capital, LLC 240,000$12,056,0002.17%
EcoR1 Capital, LLC 112,455$5,649,0001.88%
New Leaf Venture Partners, L.L.C. 43,770$2,199,0001.49%
AlpInvest Partners B.V. 12,195$613,0001.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 595,443$29,909,0000.97%
APEX CAPITAL, LLC 190,000$9,544,0000.69%
OAK RIDGE INVESTMENTS LLC 385,770$19,377,0000.43%
Lombard Odier Asset Management (USA) Corp 92,089$4,626,0000.37%
SPHERA FUNDS MANAGEMENT LTD. 65,724$3,301,0000.34%
View complete list of SAGE THERAPEUTICS INC shareholders